Company · CIK 0000906709 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NEKTAR THERAPEUTICS · NKTR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 AForm 4 → | Sep 25, 8:29 pm EDT | Roy A WhitfieldDirector | 2,000 | — | — | 16,417 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:26 pm EDT | R Scott GreerDirector | 2,000 | — | — | 22,239 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:22 pm EDT | Robert ChessDirector | 2,000 | — | — | 19,019 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:20 pm EDT | Diana BrainardDirector | 2,000 | — | — | 3,904 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:18 pm EDT | Jeffrey Robert AjerDirector | 2,000 | — | — | 4,277 | — | |
| Aug 18, 2026 SForm 4 → | Aug 20, 7:05 pm EDT | Jonathan ZalevskyChief R&D Officer | 186 | $71.98 | $13,388 | 9,570 | −1.91% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 7:03 pm EDT | Howard W RobinPresident & CEO, Director | 418 | $71.98 | $30,088 | 54,627 | −0.76% | |
| Jun 30, 2026 SForm 4 → | Jul 2, 7:06 pm EDT | Jonathan ZalevskyChief R&D Officer | 5,681 | $70.00 | $397,670 | 9,756 | −36.8% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 18, 7:08 pm EDT | Howard W RobinPresident & CEO, Director | 20,000 | $60.75 | $1,215,056 | 55,045 | −26.7% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 7:12 pm EDT | Jonathan ZalevskyChief R&D Officer | 5,538 | $60.71 | $336,212 | 15,437 | −26.4% | 10b5-1 |
| Mar 8, 2019 MForm 4 → | Mar 12, 6:18 pm EDT | R Scott GreerDirector | 10,000 | $5.14 | $51,400 | 145,083 | — | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:17 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,808 | $42.39 | $76,641 | 166,391 | −1.07% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:16 pm EST | Howard W RobinPresident & CEO, Director | 108,882 | $42.19 | $4,594,176 | 308,709 | −26.1% | plan? |
| Feb 19, 2019 MForm 4 → | Feb 21, 8:16 pm EST | Howard W RobinPresident & CEO, Director | 100,000 | $7.21 | $721,000 | 342,042 | — | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:15 pm EST | John NicholsonSVP & Chief Operating Officer | 3,822 | $42.39 | $162,015 | 170,655 | −2.19% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:14 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 3,592 | $42.39 | $152,265 | 131,702 | −2.65% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:13 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,386 | $42.39 | $101,143 | 97,143 | −2.40% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 8:13 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 3,310 | $42.39 | $140,311 | 99,374 | −3.22% | plan? |
| Feb 4, 2019 SForm 4 → | Feb 6, 7:17 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 16,119 | $42.16 | $679,577 | 168,199 | −8.75% | plan? |
| Feb 4, 2019 MForm 4 → | Feb 6, 7:17 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 16,119 | $10.69 | $172,312 | 184,318 | — | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 63,000 | $42.82 | $2,697,660 | 174,477 | −26.5% | plan? |
| Jan 28, 2019 MForm 4 → | Jan 30, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 63,000 | $10.69 | $673,470 | 237,477 | — | plan? |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:14 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 10,950 | — | — | 168,199 | — | plan? |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:13 pm EST | Howard W RobinPresident & CEO, Director | 68,450 | — | — | 317,591 | — | plan? |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:12 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 28,750 | — | — | 135,294 | — | plan? |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:11 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 18,500 | — | — | 99,529 | — | plan? |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:10 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 23,950 | — | — | 102,684 | — | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:15 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 4,016 | $38.25 | $153,612 | 157,249 | −2.49% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:14 pm EST | Howard W RobinPresident & CEO, Director | 15,326 | $38.25 | $586,220 | 249,141 | −5.80% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:14 pm EST | John NicholsonSVP & Chief Operating Officer | 5,982 | $38.25 | $228,812 | 174,477 | −3.31% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:13 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 6,515 | $38.25 | $249,199 | 106,544 | −5.76% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:12 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 4,694 | $38.25 | $179,546 | 81,029 | −5.48% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 6:11 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 4,524 | $38.25 | $173,043 | 78,734 | −5.43% | plan? |
| Nov 1, 2018 AForm 4 → | Nov 5, 6:00 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 90,000 | — | — | 161,265 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:25 pm EDT | Roy A WhitfieldDirector | 4,750 | — | — | 181,750 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:24 pm EDT | Lutz LingnauDirector | 4,750 | — | — | 23,200 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:23 pm EDT | Christopher A KueblerDirector | 4,750 | — | — | 45,250 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:22 pm EDT | R Scott GreerDirector | 4,750 | — | — | 135,083 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:21 pm EDT | Robert ChessDirector | 4,750 | — | — | 274,473 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:20 pm EDT | Jeffrey Robert AjerDirector | 4,750 | — | — | 20,500 | — | plan? |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:19 pm EDT | Karin EasthamDirector | 8,500 | — | — | 8,500 | — | plan? |
| Sep 20, 2018 SForm 4 → | Sep 21, 7:32 pm EDT | Lutz LingnauDirector | 9,000 | $56.98 | $512,820 | 18,450 | −32.8% | plan? |
| Sep 20, 2018 SForm 4 → | Sep 21, 7:29 pm EDT | Jeffrey Robert AjerDirector | 6,750 | $56.76 | $383,130 | 15,750 | −30.0% | plan? |
| Sep 19, 2018 SForm 4 → | Sep 21, 7:31 pm EDT | Robert ChessDirector | 4,500 | $56.81 | $255,645 | 269,723 | −1.64% | plan? |
| Sep 4, 2018 SForm 4 → | Sep 6, 7:12 pm EDT | R Scott GreerDirector | 10,000 | $67.39 | $673,900 | 130,333 | −7.13% | plan? |
| Sep 4, 2018 MForm 4 → | Sep 6, 7:12 pm EDT | R Scott GreerDirector | 10,000 | $5.14 | $51,400 | 140,333 | — | plan? |
| Aug 17, 2018 SForm 4 → | Aug 21, 7:32 pm EDT | Dennis L WingerDirector | 30,000 | $59.96 | $1,798,800 | 42,750 | −41.2% | plan? |
| Aug 17, 2018 MForm 4 → | Aug 21, 7:32 pm EDT | Dennis L WingerDirector | 30,000 | $14.26 | $427,800 | 57,750 | — | plan? |
| Aug 15, 2018 ADForm 4 → | Aug 16, 9:47 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,283 | $58.40 | $285,167 | 71,265 | — | plan? |
| Aug 15, 2018 ADForm 4 → | Aug 16, 9:46 pm EDT | John NicholsonSVP & Chief Operating Officer | 34,137 | $58.40 | $475,201 | 180,459 | — | plan? |
| Aug 15, 2018 ADForm 4 → | Aug 16, 9:45 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 34,207 | $58.40 | $479,289 | 113,059 | — | plan? |
| Aug 15, 2018 ADForm 4 → | Aug 16, 9:44 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 20,946 | $58.40 | $347,246 | 85,723 | — | plan? |
| Aug 15, 2018 ADForm 4 → | Aug 16, 9:43 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 32,701 | $58.40 | $391,338 | 83,258 | — | plan? |
| Aug 14, 2018 ADForm 4 → | Aug 16, 9:44 pm EDT | Howard W RobinPresident & CEO, Director | 160,889 | $40.06 | $4,021,518 | 264,467 | — | plan? |
| Aug 13, 2018 SForm 4 → | Aug 15, 7:30 pm EDT | Dennis L WingerDirector | 34,250 | $60.60 | $2,075,379 | 42,750 | −44.5% | plan? |
| Jun 25, 2018 SForm 4 → | Jun 27, 7:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | $49.52 | $6,438,036 | 224,356 | −36.7% | plan? |
| Jun 25, 2018 MForm 4 → | Jun 27, 7:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | $10.69 | $1,389,700 | 267,689 | — | plan? |
| Jun 5, 2018 PForm 4 → | Jun 7, 7:40 pm EDT | Roy A WhitfieldDirector | 5,000 | $58.04 | $290,212 | 177,000 | +2.91% | plan? |
| Jun 5, 2018 SForm 4 → | Jun 7, 7:39 pm EDT | Robert ChessDirector | 10,000 | $55.16 | $551,600 | 274,223 | −3.52% | plan? |
| Jun 5, 2018 MForm 4 → | Jun 7, 7:39 pm EDT | Robert ChessDirector | 10,000 | $14.26 | $142,600 | 284,223 | — | plan? |
| Jun 4, 2018 SForm 4 → | Jun 6, 7:42 pm EDT | R Scott GreerDirector | 10,000 | $60.28 | $602,786 | 130,333 | −7.13% | plan? |
| Jun 4, 2018 MForm 4 → | Jun 6, 7:42 pm EDT | R Scott GreerDirector | 10,000 | $5.14 | $51,400 | 138,933 | — | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:07 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 3,576 | $83.39 | $298,203 | 65,281 | −5.19% | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:06 pm EDT | Howard W RobinPresident & CEO, Director | 12,791 | $83.39 | $1,066,641 | 224,356 | −5.39% | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:05 pm EDT | John NicholsonSVP & Chief Operating Officer | 4,917 | $83.39 | $410,029 | 162,596 | −2.94% | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:03 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 4,941 | $83.39 | $412,030 | 94,798 | −4.95% | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:02 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 4,060 | $83.39 | $338,563 | 76,201 | −5.06% | plan? |
| May 16, 2018 SForm 4 → | May 18, 7:01 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 3,435 | $83.39 | $286,445 | 63,959 | −5.10% | plan? |
| May 3, 2018 SForm 4 → | May 4, 6:55 pm EDT | Robert ChessDirector | 25,000 | $82.80 | $2,070,050 | 274,223 | −8.35% | plan? |
| May 3, 2018 MForm 4 → | May 4, 6:55 pm EDT | Robert ChessDirector | 25,000 | $8.79 | $219,700 | 289,223 | — | plan? |
| May 1, 2018 SForm 4 → | May 3, 8:43 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 90,000 | $84.05 | $7,564,200 | 99,739 | −47.4% | plan? |
| May 1, 2018 MForm 4 → | May 3, 8:43 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 90,000 | $10.69 | $962,100 | 129,739 | — | plan? |
| May 1, 2018 SForm 4 → | May 3, 8:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | $84.05 | $10,926,066 | 237,147 | −35.4% | plan? |
| May 1, 2018 MForm 4 → | May 3, 8:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | $10.69 | $1,389,700 | 280,480 | — | plan? |
| Apr 17, 2018 MForm 4 → | Apr 18, 6:05 pm EDT | Roy A WhitfieldDirector | 30,000 | $14.26 | $427,800 | 172,000 | — | plan? |
| Apr 16, 2018 SForm 4 → | Apr 18, 6:03 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 13,881 | $101.46 | $1,408,366 | 68,857 | −16.8% | plan? |
| Apr 16, 2018 MForm 4 → | Apr 18, 6:03 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 13,881 | $10.69 | $148,388 | 82,738 | — | plan? |
| Apr 10, 2018 SForm 4 → | Apr 12, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 502 | $105.67 | $53,046 | 80,261 | −0.62% | plan? |
| Apr 10, 2018 MForm 4 → | Apr 12, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 502 | $7.21 | $3,619 | 80,763 | — | plan? |
| Apr 6, 2018 SForm 4 → | Apr 9, 8:22 pm EDT | R Scott GreerDirector | 30,000 | $92.22 | $2,766,600 | 130,333 | −18.7% | plan? |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:22 pm EDT | R Scott GreerDirector | 30,000 | $14.26 | $427,800 | 160,333 | — | plan? |
| Apr 6, 2018 SForm 4 → | Apr 9, 8:21 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 160,000 | $93.06 | $14,890,180 | 67,394 | −70.4% | plan? |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:21 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 160,000 | $8.52 | $1,362,400 | 116,894 | — | plan? |
| Apr 6, 2018 SForm 4 → | Apr 9, 8:20 pm EDT | Robert ChessDirector | 25,000 | $92.14 | $2,303,600 | 274,223 | −8.35% | plan? |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:20 pm EDT | Robert ChessDirector | 25,000 | $8.79 | $219,700 | 289,223 | — | plan? |
| Apr 5, 2018 SForm 4 → | Apr 9, 8:23 pm EDT | Lutz LingnauDirector | 30,000 | $101.74 | $3,052,200 | 27,450 | −52.2% | plan? |
| Apr 5, 2018 MForm 4 → | Apr 9, 8:23 pm EDT | Lutz LingnauDirector | 30,000 | $9.24 | $277,200 | 57,450 | — | plan? |
| Apr 5, 2018 SForm 4 → | Apr 9, 8:22 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 29,498 | $102.81 | $3,032,765 | 80,261 | −26.9% | plan? |
| Apr 5, 2018 MForm 4 → | Apr 9, 8:22 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 29,498 | $7.21 | $212,681 | 89,759 | — | plan? |
| Mar 6, 2018 SForm 4 → | Mar 8, 6:10 pm EST | Christopher A KueblerDirector | 40,000 | $97.60 | $3,903,914 | 40,500 | −49.7% | plan? |
| Mar 6, 2018 MForm 4 → | Mar 8, 6:10 pm EST | Christopher A KueblerDirector | 40,000 | $6.17 | $246,600 | 77,900 | — | plan? |
| Mar 6, 2018 SForm 4 → | Mar 8, 6:09 pm EST | John NicholsonSVP & Chief Operating Officer | 220,144 | $99.27 | $21,854,265 | 167,513 | −56.8% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:10 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 2,545 | $82.94 | $211,082 | 68,857 | −3.56% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:10 pm EST | Howard W RobinPresident & CEO, Director | 12,788 | $82.94 | $1,060,637 | 237,147 | −5.12% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:09 pm EST | John NicholsonSVP & Chief Operating Officer | 4,879 | $82.94 | $404,664 | 387,657 | −1.24% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:08 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 3,477 | $82.94 | $288,382 | 99,739 | −3.37% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:07 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,875 | $82.94 | $238,453 | 80,261 | −3.46% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 20, 7:07 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 2,426 | $82.94 | $201,212 | 67,394 | −3.47% | plan? |
| Jan 31, 2018 MForm 4 → | Feb 2, 6:03 pm EST | John NicholsonSVP & Chief Operating Officer | 120,000 | $11.34 | $1,360,800 | 392,536 | — | plan? |
| Jan 22, 2018 SForm 4 → | Jan 24, 6:01 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | $75.82 | $6,318,308 | 249,935 | −25.0% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 AForm 4 → | Sep 25, 8:29 pm EDT | Roy A WhitfieldDirector | 4,000 | — | — | 4,000 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:26 pm EDT | R Scott GreerDirector | 4,000 | — | — | 4,000 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:22 pm EDT | Robert ChessDirector | 4,000 | — | — | 4,000 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:20 pm EDT | Diana BrainardDirector | 4,000 | — | — | 4,000 | — | |
| Sep 23, 2026 AForm 4 → | Sep 25, 8:18 pm EDT | Jeffrey Robert AjerDirector | 4,000 | — | — | 4,000 | — | |
| Jul 24, 2026 AForm 4 → | Jul 24, 6:35 pm EDT | Jonathan ZalevskyChief R&D Officer | 16,500 | — | — | 16,500 | — | |
| Jul 24, 2026 AForm 4 → | Jul 24, 6:34 pm EDT | Howard W RobinPresident & CEO, Director | 57,200 | — | — | 57,200 | — | |
| Mar 8, 2019 MForm 4 → | Mar 12, 6:18 pm EDT | R Scott GreerDirector | 10,000 | — | — | 0 | — | |
| Feb 19, 2019 MForm 4 → | Feb 21, 8:16 pm EST | Howard W RobinPresident & CEO, Director | 100,000 | — | — | 100,000 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 7:17 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 16,119 | — | — | 0 | — | |
| Jan 28, 2019 MForm 4 → | Jan 30, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 63,000 | $10.69 | $673,470 | 0 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:14 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 22,150 | — | — | 22,150 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:13 pm EST | Howard W RobinPresident & CEO, Director | 138,350 | — | — | 138,350 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:12 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 58,100 | — | — | 58,100 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:11 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 37,350 | — | — | 37,350 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 6:10 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 48,400 | — | — | 48,400 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:25 pm EDT | Roy A WhitfieldDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:24 pm EDT | Lutz LingnauDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:23 pm EDT | Christopher A KueblerDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:22 pm EDT | R Scott GreerDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:21 pm EDT | Robert ChessDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:20 pm EDT | Jeffrey Robert AjerDirector | 9,500 | — | — | 9,500 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 8:19 pm EDT | Karin EasthamDirector | 17,000 | — | — | 17,000 | — | |
| Sep 4, 2018 MForm 4 → | Sep 6, 7:12 pm EDT | R Scott GreerDirector | 10,000 | — | — | 10,000 | — | |
| Aug 17, 2018 MForm 4 → | Aug 21, 7:32 pm EDT | Dennis L WingerDirector | 30,000 | $14.26 | $427,800 | 0 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 9:47 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 26,250 | — | — | 26,250 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 9:46 pm EDT | John NicholsonSVP & Chief Operating Officer | 65,000 | — | — | 65,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 9:45 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 65,000 | — | — | 65,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 9:44 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 37,500 | — | — | 37,500 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 9:43 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 65,000 | — | — | 65,000 | — | |
| Aug 14, 2018 AMForm 4 → | Aug 16, 9:44 pm EDT | Howard W RobinPresident & CEO, Director | 191,250 | — | — | 151,250 | — | |
| Jun 25, 2018 MForm 4 → | Jun 27, 7:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | — | — | 40,000 | — | |
| Jun 5, 2018 MForm 4 → | Jun 7, 7:39 pm EDT | Robert ChessDirector | 10,000 | — | — | 0 | — | |
| Jun 4, 2018 MForm 4 → | Jun 6, 7:42 pm EDT | R Scott GreerDirector | 10,000 | — | — | 20,000 | — | |
| May 3, 2018 MForm 4 → | May 4, 6:55 pm EDT | Robert ChessDirector | 25,000 | — | — | 0 | — | |
| May 1, 2018 MForm 4 → | May 3, 8:43 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 90,000 | — | — | 0 | — | |
| May 1, 2018 MForm 4 → | May 3, 8:42 pm EDT | Howard W RobinPresident & CEO, Director | 130,000 | — | — | 170,000 | — | |
| Apr 17, 2018 MForm 4 → | Apr 18, 6:05 pm EDT | Roy A WhitfieldDirector | 30,000 | — | — | 0 | — | |
| Apr 16, 2018 MForm 4 → | Apr 18, 6:03 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 13,881 | — | — | 16,119 | — | |
| Apr 10, 2018 MForm 4 → | Apr 12, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 502 | — | — | 32,500 | — | |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:22 pm EDT | R Scott GreerDirector | 30,000 | — | — | 0 | — | |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:21 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 160,000 | — | — | 0 | — | |
| Apr 6, 2018 MForm 4 → | Apr 9, 8:20 pm EDT | Robert ChessDirector | 25,000 | — | — | 15,000 | — | |
| Apr 5, 2018 MForm 4 → | Apr 9, 8:23 pm EDT | Lutz LingnauDirector | 30,000 | — | — | 10,000 | — | |
| Apr 5, 2018 MForm 4 → | Apr 9, 8:22 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 29,498 | — | — | 33,002 | — | |
| Mar 6, 2018 MForm 4 → | Mar 8, 6:10 pm EST | Christopher A KueblerDirector | 40,000 | — | — | 30,000 | — | |
| Jan 31, 2018 MForm 4 → | Feb 2, 6:03 pm EST | John NicholsonSVP & Chief Operating Officer | 120,000 | — | — | 0 | — | |
| Jan 22, 2018 MForm 4 → | Jan 24, 6:01 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | — | — | 0 | — | |
| Jan 4, 2018 MForm 4 → | Jan 8, 6:07 pm EST | Dennis L WingerDirector | 33,750 | — | — | 0 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 6:01 pm EST | Christopher A KueblerDirector | 30,000 | — | — | 0 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:29 pm EST | Howard W RobinPresident & CEO, Director | 151,250 | — | — | 151,250 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:28 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 26,250 | — | — | 26,250 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:28 pm EST | John NicholsonSVP & Chief Operating Officer | 65,000 | — | — | 65,000 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:27 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 65,000 | — | — | 65,000 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:26 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 37,500 | — | — | 37,500 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:25 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 65,000 | — | — | 65,000 | — | |
| Dec 13, 2017 MForm 4 → | Dec 15, 6:00 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | — | — | 83,333 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 37,500 | — | — | 37,500 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:06 pm EST | Howard W RobinPresident & CEO, Director | 137,500 | — | — | 137,500 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:05 pm EST | John NicholsonSVP & Chief Operating Officer | 50,000 | — | — | 50,000 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:05 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:04 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 37,500 | — | — | 37,500 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:03 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Nov 15, 2017 AForm 4 → | Nov 17, 6:03 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 43,750 | — | — | 43,750 | — | |
| Nov 13, 2017 MForm 4 → | Nov 15, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 25,000 | — | — | 0 | — | |
| Nov 6, 2017 MForm 4 → | Nov 8, 6:02 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 22,417 | — | — | 0 | — | |
| Nov 6, 2017 MForm 4 → | Nov 8, 6:01 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 396,323 | — | — | 0 | — | |
| Nov 1, 2017 MForm 4 → | Nov 3, 6:07 pm EDT | Howard W RobinPresident & CEO, Director | 83,334 | — | — | 166,666 | — | |
| Oct 9, 2017 MForm 4 → | Oct 10, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | — | — | 250,000 | — | |
| Oct 5, 2017 MForm 4 → | Oct 10, 6:07 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 7,583 | — | — | 22,417 | — | late |
| Oct 5, 2017 MForm 4 → | Oct 10, 6:06 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 43,677 | — | — | 396,323 | — | late |
| Oct 2, 2017 MForm 4 → | Oct 3, 6:06 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 120,000 | — | — | 0 | — | |
| Sep 29, 2017 MForm 4 → | Oct 3, 6:02 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 100,000 | — | — | 313,752 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 5:02 pm EDT | Jeffrey Robert AjerDirector | 56,250 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:57 pm EDT | Dennis L WingerDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:56 pm EDT | Christopher A KueblerDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:51 pm EDT | Roy A WhitfieldDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:49 pm EDT | Lutz LingnauDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:46 pm EDT | Joseph J KrivulkaDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:43 pm EDT | R Scott GreerDirector | 22,500 | — | — | 22,500 | — | |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:40 pm EDT | Robert ChessDirector | 22,500 | — | — | 22,500 | — | |
| Sep 6, 2017 MForm 4 → | Sep 8, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | — | — | 333,333 | — | |
| Aug 16, 2017 MForm 4 → | Aug 18, 7:05 pm EDT | Howard W RobinPresident & CEO, Director | 83,334 | — | — | 416,666 | — | |
| Jul 18, 2017 MForm 4 → | Jul 20, 5:08 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 54,920 | — | — | 413,752 | — | |
| Jul 14, 2017 MForm 4 → | Jul 18, 8:02 pm EDT | Lutz LingnauDirector | 30,000 | — | — | 0 | — | |
| Jul 11, 2017 MForm 4 → | Jul 13, 8:01 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 45,080 | — | — | 468,672 | — | |
| Jun 26, 2017 MForm 4 → | Jun 28, 6:05 pm EDT | Joseph J KrivulkaDirector | 15,000 | — | — | 0 | — | |
| Jun 7, 2017 MForm 4 → | Jun 9, 6:02 pm EDT | John NicholsonSVP & Chief Operating Officer | 150,000 | — | — | 0 | — | |
| May 15, 2017 MForm 4 → | May 17, 6:02 pm EDT | Robert ChessDirector | 5,000 | — | — | 0 | — | |
| Apr 17, 2017 MForm 4 → | Apr 19, 7:30 pm EDT | Robert ChessDirector | 5,000 | — | — | 5,000 | — | |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:07 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 100,000 | — | — | 440,000 | — | |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 180,000 | — | — | 0 | — | |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:01 pm EDT | Christopher A KueblerDirector | 15,000 | — | — | 0 | — | |
| Mar 20, 2017 MForm 4 → | Mar 22, 6:04 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 112,500 | — | — | 0 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 6:02 pm EDT | Roy A WhitfieldDirector | 14,000 | — | — | 0 | — | |
| Mar 14, 2017 MForm 4 → | Mar 16, 6:02 pm EDT | Robert ChessDirector | 5,000 | — | — | 10,000 | — | |
| Mar 2, 2017 MForm 4 → | Mar 3, 7:04 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 200,000 | — | — | 0 | — | |
| Feb 21, 2017 MForm 4 → | Feb 23, 6:32 pm EST | Lutz LingnauDirector | 30,000 | — | — | 0 | — | |
| Feb 10, 2017 MForm 4 → | Feb 10, 8:11 pm EST | John NicholsonSVP & Chief Operating Officer | 45,000 | — | — | 0 | — | |
| Feb 8, 2017 MForm 4 → | Feb 10, 8:10 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 0 | — |